Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Feb;18(2):511-513.
doi: 10.1016/j.cgh.2019.04.035. Epub 2019 Apr 19.

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017

Affiliations
Observational Study

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017

Suk Seo et al. Clin Gastroenterol Hepatol. 2020 Feb.

Abstract

Strategic planning for hepatitis C virus (HCV) screening and treatment requires up-to-date information on the prevalence of HCV spontaneous clearance. Published estimates of HCV spontaneous clearance range from 15% to 60%.1-3 We conducted an observational study over 20 years to evaluate trends in the prevalence of HCV spontaneous clearance. Our goals were to estimate the proportion of HCV-antibody-positive patients who were viremic, and to identify factors associated with viremia, thus facilitating prediction of the number of patients needing treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Prevalence of spontaneous clearance of HCV by year of PCR test during 1998–2017.
HCV, hepatitis C virus; Ab, antibody. Solid line displays percent with spontaneous clearance for all patients testing HCV-antibody positive. Dotted and dashed lines display percentage with spontaneous clearance for birth years ≥1965, 1945–1965, and <1945.

References

    1. Bulteel N, Partha Sarathy P, Forrest E, et al. Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J Hepatol 2016;65:266–72. - PubMed
    1. Santantonio T, Sinisi E, Guastadisegni A, et al. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003;35:104–13. - PubMed
    1. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005;9:383–98, vi. - PubMed
    1. Conway R, Doran MF, O’Shea FD, et al. The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis. Clin Rheumatol 2014;33:1823–7. - PubMed
    1. Mohan P, Rajasekaran M, Ramanathan P, et al. Prevalence of hepatitis C virus antibodies in systemic lupus erythematosus. Eur J Gastroenterol Hepatol 2009;21:1437–8. - PubMed

Publication types

Substances